Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer prevention: the guidelines.

Konstantin H Dragnev1, Diane Stover, Ethan Dmitrovsky

  • 1Norris Cotton Cancer Center and Dartmouth Medical School, Lebanon, NH 03756, USA. dragnev@dartmouth.edu

Chest
|January 16, 2003
PubMed
Summary

Pharmacologic lung cancer chemoprevention strategies, including beta-carotene and isotretinoin, have not shown benefits and may increase risk in smokers. Further research is needed to identify effective lung cancer prevention agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Derivation and characterization of ubiquitin-specific protease 18 inhibitors.

JCI insight·2026
Same author

CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance.

Molecular cancer therapeutics·2026
Same author

Targeting KIFC1 to disrupt centrosome clustering and trigger anaphase catastrophe in small-cell lung cancer.

JCI insight·2026
Same author

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026

Area of Science:

  • Oncology
  • Pulmonology
  • Pharmacology

Background:

  • Lung cancer develops through a multi-step process of carcinogenesis.
  • Cancer chemoprevention aims to arrest or reverse neoplastic progression using pharmacologic treatments.
  • Despite smoking cessation efforts, former smokers and never-smokers remain at risk for lung cancer.

Framework:

  • This review examines pharmacologic strategies for lung cancer prevention.
  • It evaluates evidence from preclinical, clinical, and epidemiologic studies.
  • Focus is placed on candidate chemopreventive agents and their efficacy.

Implementation:

  • Randomized clinical trials of beta-carotene, retinol, isotretinoin, and N-acetyl-cysteine showed no benefit for primary or tertiary lung cancer prevention.

Related Experiment Videos

  • Some agents, like beta-carotene and isotretinoin, may increase lung cancer risk, particularly in current smokers.
  • There is a critical need for in vitro models to elucidate chemopreventive pathways in the lung.

    • Implications:

    • Understanding cancer prevention mechanisms is crucial for designing effective clinical trials and identifying new therapeutic targets.
    • Currently, no agent should be used for lung cancer prevention outside of a clinical trial setting.
    • Further research is essential to develop safe and effective lung cancer chemoprevention strategies.